Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enalapril in pediatric Fontan patients: effects on fluid regulation and cardiovascular function
NL-OMON46953Phase 4Active, not recruiting
- Sponsor
- Leiden University Medical Center
- Start
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of enalapril in Cardiovascular Malformation (CVM), Single Ventricle Heart Defects and Fontan circulation (2 arms), sponsored by Leiden University Medical Center. Primary endpoints: VO2peak, Heart rate variability and 3 more. Started Jun 2017; status: active, not recruiting.
02
Drugs
enalapril
03
Conditions
Cardiovascular Malformation (CVM)Single Ventricle Heart DefectsFontan circulation
Beyond the preview
Go deeper on NL-OMON46953.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON46953.